Litigation Details for UCB Inc. v. Zydus Worldwide DMCC (D. Del. 2016)
✉ Email this page to a colleague
UCB Inc. v. Zydus Worldwide DMCC (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-11-03 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | |
| Patents | 6,884,434; 8,246,979; 8,617,591 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB Inc. v. Zydus Worldwide DMCC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for UCB Inc. v. Zydus Worldwide DMCC (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-06-01 | 137 | Opinion - Memorandum Opinion | Zydus"), alleging infringement of U.S. Patent Nos. 6,884,434, 8,617,591, and 8,246,979. Presently… one term appearing in the '434 patent. The '434 patent describes and claims transdermal therapeutic…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification …13 of the ' 979 patent and claims 1, 2, 3, 10, and 11 of the '59 1 patent, as "particulate | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
